Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Factors influencing the prognosis of patients with heart failure with preserved ejection fraction (HFpEF) have been extensively studied. Previous studies have found that elevated serum total bilirubin levels are associated with cardiac death, heart failure readmission, and all-cause mortality in patients with chronic heart failure. However, the relationship between direct bilirubin and prognosis in patients with HFpEF is unclear.
Eligibility Criteria
Inclusion Criteria: * Adult aged ≥18 years old; * Diagnosed with HFpEF. Diagnostic criteria including: 1. left ventricular ejection fraction ≥ 50%; 2. with the symptoms and/or signs of heart failure; 3. Patients in sinus rhythm:BNP≥35pg/ml and/or NT-proBNP≥125pg/ml;Patients with atrial fibrillation:BNP≥105pg/ml and/or NT-proBNP≥365pg/ml. Exclusion Criteria: * LVEF less than 49% at any time